Skip to main content

Table 1 Baseline clinical characteristics of SAVR vs TAVI patients

From: Determinants of clinical improvement after surgical replacement or transcatheter aortic valve implantation for isolated aortic stenosis

  SAVR (n = 45) TAVI (n = 42) p-value
Age (years) [Me (P25-P75)] 73 (68 - 78) 83.5 (79 - 87) <0.001
Female gender [n(%)] 28 (62.2) 26 (61.9) 0.976
BSA ( m 2 ) [Me (P25-P75)] 1.76 (1.57 - 1.86) 1.75 (1.6 - 1.8) 0.639
Hypertension [n(%)] 28 (62.2) 35 (83.3) 0.028
Diabetes mellitus [n(%)] 13 (28.9) 11 (26.2) 0.778
Dislipidemia [n(%)] 28 (62.2) 26 (61.9) 0.976
COPD [n(%)] 12 (26.7) 19 (45.2) 0.071
PAD [n(%)] 3 (6.7) 12 (28.6) 0.007
Atrial Fibrilation [n(%)] 0 (0) 7 (16.7) 0.004
Logistic Euroscore 6.18 ± 2.71 17.86 ± 9.55 <0.001
NYHA class III - IV [n(%)] 12 (26.7) 37 (88.1) <0.001
  1. BSA = body surface area; COPD = chronic obstructive pulmonary disease; PAD = peripheral artery disease; NYHA = New York Heart Association; values are mean ± SD or median (P25-P75) according to distribution, or n (%).